Key Market Indicators
Romanian insulin exports are projected to reach approximately $7.5 million by 2028, up from about $6.6 million in 2023, marking an average annual growth rate of 2%. Since 2001, the country's insulin supply has consistently increased by 2% year on year. In 2023, Romania was ranked 18th globally in insulin exports, with Lithuania slightly ahead at $6.6 million. France, Italy, and China occupied the second, third, and fourth positions, respectively. Meanwhile, Romanian insulin imports are expected to climb to roughly $140 million by 2028 from around $122 million in 2023, also reflecting an average annual growth rate of 2%. Since 1997, the country's demand for insulin has grown by 2% each year.
